amiodarone has been researched along with Atherogenesis in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone effectiveness was lowered by lipoprotein alpha-tocopherol enrichment, suggesting some drug-alpha-tocopherol interaction and less lipid pharmacological protection at higher alpha-tocopheroxyl radical generation." | 1.34 | Amiodarone inhibits tocopherol-mediated human lipoprotein peroxidation. ( Ciofani, G; Cuccurullo, F; Giamberardino, MA; Lapenna, D; Neri, M; Pierdomenico, SD, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lapenna, D | 1 |
| Ciofani, G | 1 |
| Pierdomenico, SD | 1 |
| Neri, M | 1 |
| Giamberardino, MA | 1 |
| Cuccurullo, F | 1 |
1 other study available for amiodarone and Atherogenesis
| Article | Year |
|---|---|
Amiodarone inhibits tocopherol-mediated human lipoprotein peroxidation.
Topics: Amiodarone; Atherosclerosis; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; Lipi | 2007 |